Hepatic and Pancreatic Encephalopathy

Hepatic encephalopathy (HE) is a precondition for the diagnosis of acute liver failure and a frequent complication of cirrhosis. Three types of HE are differentiated: type A in patients with acute liver failure; type B in patients with portosystemic shunts in the absence of liver dysfunction; and type C in patients with cirrhosis. HE symptoms are nonspecific; patients present with an alteration of cognition and sometimes consciousness accompanied by altered motor function. Patients with types B and C may have extrapyramidal and cerebellar disturbances in addition to pyramidal signs. Minimal HE is diagnosed when a patient without clinical signs of cerebral dysfunction has abnormalities on neuropsychologic or neurophysiologic testing. Hyperammonemia and the effects of inflammatory cytokines are considered to play a key role in the development of HE. In severe forms of acute liver failure, HE is accompanied by severe brain edema. Therapy of HE aims to reduce plasma ammonia and proinflammatory cytokine levels. When medical treatment is insufficient, liver transplantation becomes necessary. In contrast to HE, pancreatic encephalopathy is less well defined; the pathophysiology is uncertain and thus treatment remains symptomatic.

• Publication year

  2021

• Venue

  Aminoff's Neurology and General Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-12-407710-2.00012-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Update on the management of acute liver failure

  2019cited by this paper
• Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology

  2019cited by this paper
• Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence

  2018cited by this paper
• Qualifying and quantifying minimal hepatic encephalopathy

  2016cited by this paper
• Portosystemic encephalopathy.

  2014cited by this paper
• Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

  2014cited by this paper
• Rifaximin is an efficacious treatment for the parkinsonian phenotype of hepatic encephalopathy

  2013cited by this paper
• Lessons from look-back in acute liver failure? A single centre experience of 3300 patients.

  2013cited by this paper
• Antibiotics for the treatment of hepatic encephalopathy

  2013cited by this paper
• Brain edema in acute liver failure and chronic liver disease: similarities and differences.

  2013cited by this paper
• Cirrhosis-related Parkinsonism: prevalence, mechanisms and response to treatments.

  2013cited by this paper
• Acute liver failure and the brain: a look through the crystal ball

  2013cited by this paper
• Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates

  2013cited by this paper
• Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

  2013cited by this paper
• The neurological manifestations of acute liver failure.

  2012cited by this paper
• Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: An open labeled randomized controlled trial of lactulose versus no lactulose

  2012cited by this paper
• Liver-brain proinflammatory signalling in acute liver failure: Role in the pathogenesis of hepatic encephalopathy and brain edema

  2012cited by this paper
• Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis

  2012cited by this paper
• Central and Extrapontine Myelinolysis Affecting the Brain and Spinal Cord. An Unusual Presentation of Pancreatic Encephalopathy

  2012cited by this paper
• Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure.

  2012cited by this paper
• 56 THE PROPHYLACTIVE EFFECT OF MILD HYPOTHERMIA TO PREVENT BRAIN EDEMA IN PATIENTS WITH ACUTE LIVER FAILURE: RESULTS OF A MULTICENTER RANDOMIZED, CONTROLLED TRIAL

  2011cited by this paper
• Electroencephalography in patients with cirrhosis.

  2011cited by this paper
• A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy

  2011cited by this paper
• Review article: the design of clinical trials in hepatic encephalopathy – an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement

  2011cited by this paper
• Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis

  2011cited by this paper
• Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study

  2011cited by this paper
• Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy. A comparative study of 154 patients with liver disease

  2011cited by this paper
• Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)

  2011cited by this paper
• Prophylaxis of hepatic encephalopathy in acute variceal bleed: A randomized controlled trial of lactulose versus no lactulose

  2011cited by this paper
• Propofol sedation during endoscopy in patients with cirrhosis, and utility of psychometric tests and critical flicker frequency in assessment of recovery from sedation

  2011cited by this paper
• Improving the inhibitory control task to detect minimal hepatic encephalopathy.

  2010cited by this paper
• Rifaximin treatment in hepatic encephalopathy.

  2010cited by this paper
• Neurological Management of Fulminant Hepatic Failure

  2010cited by this paper
• Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver

  2010cited by this paper
• Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy

  2010cited by this paper
• Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease

  2010cited by this paper
• Reversal of hepatic myelopathy after liver transplantation: Fifteen plus one

  2010cited by this paper
• Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy

  2010cited by this paper
• Effect of Lower-Molecular Weight Heparin in the Prevention of Pancreatic Encephalopathy in the Patient With Severe Acute Pancreatitis

  2010cited by this paper
• Single-Photon Emission Computed Tomography in Diagnosis and Differential Diagnosis of Parkinson’s Disease

  2010cited by this paper
• Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.

  2009cited by this paper
• Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.

  2009cited by this paper
• Signaling factors in the mechanism of ammonia neurotoxicity

  2009cited by this paper
• Rare and Unusual … Or Are They? Less Commonly Diagnosed Encephalopathies Associated with Systemic Disease

  2009cited by this paper
• Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline

  2009cited by this paper
• Acquired hepatocerebral degeneration

  2009cited by this paper
• Thiamine deficiency-related brain dysfunction in chronic liver failure

  2009cited by this paper
• Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines

  2009cited by this paper
• Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines

  2009cited by this paper
• Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo

  2008cited by this paper
• Pathogenetic mechanisms of hepatic encephalopathy

  2008cited by this paper
• Inhibitory Control Test Is a Simple Method to Diagnose Minimal Hepatic Encephalopathy and Predict Development of Overt Hepatic Encephalopathy

  2007cited by this paper
• Manganese: recent advances in understanding its transport and neurotoxicity.

  2007cited by this paper
• Pathogenesis of hepatic encephalopathy: the tumour necrosis factor‐α theory

  2007cited by this paper
• Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis.

  2007cited by this paper
• Neuronal cell death in hepatic encephalopathy

  2007cited by this paper
• Value of the critical flicker frequency in patients with minimal hepatic encephalopathy

  2007cited by this paper
• Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure

  2007cited by this paper
• Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant.

  2007cited by this paper
• Persistent Arterial Hyperammonemia Increases the Concentration of Glutamine and Alanine in the Brain and Correlates with Intracranial Pressure in Patients with Fulminant Hepatic Failure

  2006cited by this paper
• Pancreatic encephalopathy and Wernicke encephalopathy in association with acute pancreatitis: a clinical study.

  2006cited by this paper
• Pancreatic encephalopathy--a rare complication of a common disease.

  2006cited by this paper
• Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm

  2006cited by this paper
• AASLD position paper: The management of acute liver failure

  2005cited by this paper
• Ammonia and Hepatic Encephalopathy: The More Things Change, the More They Remain the Same

  2005cited by this paper
• Treatment of hepatic encephalopathy.

  2005cited by this paper
• Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy

  2005cited by this paper
• Severe diffuse white matter lesions in a patient with pancreatic encephalopathy

  2004cited by this paper
• Combined Effects of Ammonia and Manganese on Astrocytes in Culture

  2004cited by this paper
• Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia.

  2004cited by this paper
• Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension.

  2004cited by this paper
• Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

  2004cited by this paper
• The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure

  2004cited by this paper
• Liver transplantation improves hepatic myelopathy: evidence by three cases.

  2003cited by this paper
• Pathogenesis of Hepatic Encephalopathy in Acute Liver Failure

  2003cited by this paper
• Infection and the progression of hepatic encephalopathy in acute liver failure.

  2003cited by this paper
• Correlation between ammonia levels and the severity of hepatic encephalopathy.

  2003cited by this paper
• Fatal brain stem event complicating acute pancreatitis.

  2003cited by this paper
• Branched-chain amino acids for hepatic encephalopathy.

  2003cited by this paper
• Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.

  2003cited by this paper
• Critical flicker frequency for quantification of low‐grade hepatic encephalopathy

  2002cited by this paper
• Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

  2002cited by this paper
• Pathophysiology of Hepatic Encephalopathy: A New Look at Ammonia

  2002cited by this paper
• Clinical Significance of Basal Ganglia Alterations at Brain MRI and 1H MRS in Cirrhosis and Role in the Pathogenesis of Hepatic Encephalopathy

  2002cited by this paper
• Correlations Between Cerebral Glucose Metabolism and Neuropsychological Test Performance in Nonalcoholic Cirrhotics

  2002cited by this paper
• Pancreatic encephalopathy: a 7-year follow-up case report and review of the literature

  2002cited by this paper
• Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?

  2001cited by this paper
• Neuropsychological characterization of hepatic encephalopathy.

  2001cited by this paper
• "What's in a name?" Improving the care of cirrhotics.

  2000cited by this paper
• Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

  1999cited by this paper
• Cerebral herniation in patients with acute E liver failure is correlated with arterial ammonia concentration

  1999cited by this paper
• Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end‐stage liver disease

  1997cited by this paper
• An image of the brain in patients with liver disease.

  1997cited by this paper
• Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.

  1996cited by this paper
• Increased manganese concentrations in pallidum of cirrhotic patients.

  1995cited by this paper
• Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation

  1995cited by this paper
• Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy

  1995cited by this paper
• Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure

  1992cited by this paper
• Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.

  1992cited by this paper
• Liver cirrhosis in Italy. A multicentre study on presenting modalities and the impact on health care resources. National Project on Liver Cirrhosis Group.

  1991cited by this paper

• No citing papers are available for this paper.